Dr. Paul Langley is an economist who received his undergraduate degree from the University of Hull and postgraduate degrees from Carleton University and Queen's University. He has taught at universities in the UK and Australia and has held visiting positions in the US and Canada. His research initially focused on labor economics but shifted to health economics and economic evaluations of pharmaceuticals in the early 1990s. He has held professor positions at the University of Arizona and University of Colorado focusing on pharmaceutical economics. He also worked as a health economics manager for 3M Pharmaceuticals. Currently, he runs his own consulting firm and is an adjunct professor at the University of Minnesota.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
Health economics is the study of how scarce resources are allocated among alternative uses for health care to maximize welfare. It uses economic concepts and tools to examine how individuals and societies choose to spend their available resources on health and health care. Some key aspects of health economics include examining costs and benefits of health policies and programs, evaluating efficiency and effectiveness of different treatment options, and understanding how economic factors influence health care utilization and outcomes. Common tools used in health economic analysis include cost analysis, cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis.
Need for economic evaluation in healthcare sectorsamthamby79
This document discusses key concepts in pharmacoeconomics including defining economic evaluations, identifying different cost perspectives, classifying types of costs, and comparing alternatives in economic analyses. Specifically, it outlines how economic evaluations analyze the costs and outcomes of various treatment options, defines direct medical costs, direct non-medical costs, and indirect non-medical costs from different stakeholder perspectives, and explains how costs should consider both monetary inputs and health-related outcomes.
Page Martin is a full-stack web developer with skills in CSS, HTML, JavaScript, jQuery, Angular, Node.js, Express, MongoDB, and more. Currently working as a junior application developer at Charter Communications where responsibilities include unit testing existing code using Jasmine and front-end development using pure JavaScript. Previous experience includes leading development of an internal tool using Angular2 and the MEAN stack at Charter Communications and assisting in lectures while completing a 12-week immersive web development bootcamp at DevMountain focused on the MEAN stack.
Sunetra Banerjee has over 10 years of experience in software QA testing and development. She has led testing teams of up to 15 members across multiple projects. Her experience includes testing web, mobile, and mainframe applications using Agile and Waterfall methodologies. She is proficient in test planning, defect tracking, automation, and creating test reports.
Brenton Lorenzo Williams has over 15 years of experience in automotive repair, retail management, and customer service. His resume lists positions as an Assistant Mechanic, Assistant and Store Manager, Bail Bonding Agent, Automotive Technician, and Resource Technician. He has skills in small engine and vehicle repair, inventory management, sales, customer service, computer maintenance, and operating systems. Williams seeks to leverage his broad experience and technical abilities.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
This book introduces students to health economics and uses economic concepts and empirical evidence to explain how health care institutions and markets function. It examines the subject from microeconomic and macroeconomic perspectives, including the role of health and health care within the overall economy. The book can be used for undergraduate courses in U.S. health economics or global health economics, and contains material suitable for master's courses related to nursing, hospitals, and pharmaceuticals. Supplementary instructor materials are available online.
Health economics is the study of how scarce resources are allocated among alternative uses for health care to maximize welfare. It uses economic concepts and tools to examine how individuals and societies choose to spend their available resources on health and health care. Some key aspects of health economics include examining costs and benefits of health policies and programs, evaluating efficiency and effectiveness of different treatment options, and understanding how economic factors influence health care utilization and outcomes. Common tools used in health economic analysis include cost analysis, cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis.
Need for economic evaluation in healthcare sectorsamthamby79
This document discusses key concepts in pharmacoeconomics including defining economic evaluations, identifying different cost perspectives, classifying types of costs, and comparing alternatives in economic analyses. Specifically, it outlines how economic evaluations analyze the costs and outcomes of various treatment options, defines direct medical costs, direct non-medical costs, and indirect non-medical costs from different stakeholder perspectives, and explains how costs should consider both monetary inputs and health-related outcomes.
Page Martin is a full-stack web developer with skills in CSS, HTML, JavaScript, jQuery, Angular, Node.js, Express, MongoDB, and more. Currently working as a junior application developer at Charter Communications where responsibilities include unit testing existing code using Jasmine and front-end development using pure JavaScript. Previous experience includes leading development of an internal tool using Angular2 and the MEAN stack at Charter Communications and assisting in lectures while completing a 12-week immersive web development bootcamp at DevMountain focused on the MEAN stack.
Sunetra Banerjee has over 10 years of experience in software QA testing and development. She has led testing teams of up to 15 members across multiple projects. Her experience includes testing web, mobile, and mainframe applications using Agile and Waterfall methodologies. She is proficient in test planning, defect tracking, automation, and creating test reports.
Brenton Lorenzo Williams has over 15 years of experience in automotive repair, retail management, and customer service. His resume lists positions as an Assistant Mechanic, Assistant and Store Manager, Bail Bonding Agent, Automotive Technician, and Resource Technician. He has skills in small engine and vehicle repair, inventory management, sales, customer service, computer maintenance, and operating systems. Williams seeks to leverage his broad experience and technical abilities.
Maria Dj Keiser is a FINRA registered Compliance Analyst with over 30 years of experience in administrative, operational, and compliance roles. She has expertise in analyzing customer and firm risk, educating staff, and resolving complex issues. Her most recent roles include working as a Compliance Advisor for Lumen Legal and as a Compliance Analyst for Investment Professional Inc., where she conducted suitability reviews and ensured compliance. She aims to enhance business processes and optimize profitability through leadership, problem solving, and implementing revenue-generating activities.
Sudhir hadoop and Data warehousing resume Sudhir Saxena
Overall 5.8 Years of Professional IT experience in Data Warehousing and Business Intelligence.
Having one year onsite experience in Mexico and USA with USAA Client, USA.
Having good Knowledge in Bigdata, Hadoop, Pig, Hive, Sqoop, Hbase, Python, Spark, Scala.
New Vision Youth Services seeks to help the over 500 foster youth who age out of the foster care system in Virginia each year. These youth face numerous challenges as they transition to independent living without a family support system. New Vision provides services like life skills training, education assistance, job readiness support, and health information to prepare foster youth for adulthood. A key program connects college-aged former foster youth with mentors who serve as role models and help them navigate challenges like choosing housing and transportation. The mentors aim to fill the gap left by the lack of family for these at-risk young adults.
This document is a resume for Vajiha Wadwan, a senior systems engineer with 3 years of experience in application development in the banking and finance domain. She has experience with programming languages like Perl, Shell Scripting, C, C++, Pig, Hive, and databases like DB2, Netezza. She has worked on projects involving marketing campaigns, credit card data analytics, and migration from AIX to Linux. Her roles included developing code, testing, documentation, and coordinating with teams. She has a Bachelor's degree in Information Technology.
As an accomplished developer with over 5 years’ experience in the field of Zope/Plone 3(expert), 4(expert) anf 5(intermediate)/Python. I am well positioned to join your company and make an immediate positive impression. My key areas of expertise include, but are not limited to the following:
· A solid background in Plone CMS, Zope and Python.
· Good knowledge in Python 2.X, Linux, Unix OS, MySQL, PostgreSQL , CSS3, HTML, JavaScript, Ajax, J Query and J SON, XML parsing etc.
This document provides a summary of the candidate's background and qualifications. The candidate has over 6 years of experience in test design, execution, and as a technical lead. They have a Bachelor's degree in Electronics and Telecommunications Engineering. Their areas of expertise include requirement analysis, test planning, Android and cloud application testing, connectivity testing, and tools like Appium and JMeter. They have led several projects involving testing of IMS protocols, MirrorLink, clinical applications, and FOTA systems.
Our client in Amsterdam is seeking a front-end developer to work on their communication cloud services and intelligent applications using machine learning. As part of an agile development team, the ideal candidate will translate designs into code, ensure cross-browser compatibility, and optimize applications for speed and scalability. Responsibilities include collaborating with others to design new solutions and troubleshoot customer issues. The position offers a competitive salary and benefits package in a diverse, fast-paced work environment.
Vinay Rohilla is a software engineer with 3.8 years of experience seeking a middle-level role in software testing and quality assurance. He has a B.Tech in Information Technology and is currently working at HCL Technologies. He has experience in manual testing, test planning, quality assurance processes, agile methodology, and working with various testing methodologies. At HCL, his responsibilities include maintaining testing logs, writing test cases, guiding junior team members, and ensuring quality assurance standards are met.
This document is a resume for Aneesh Mohan detailing his background and experience. It summarizes that he has over 5 years of experience in information technology in India and the Gulf region. He is seeking a job in IT where he can apply his skills and experience in software, hardware, databases, systems, and networks. The resume lists his technical skills and qualifications and provides details on his past roles and responsibilities at various companies.
S. Ramkumar is a software developer with over 5 years of experience in Python, Perl, and Unix shell scripting. He has worked on projects for clients like Verizon and Morgan Stanley, developing scripts for automation, data processing, reporting and more. His skills include writing scripts for tasks like system monitoring, file transfer, database integration, and report generation. He is looking for a challenging position that utilizes his programming and problem-solving abilities.
Tony Lockett has over 25 years of experience in the pharmaceutical and medical devices industry. He has acted as a consultant advising clients on regulatory and clinical strategies, and has also acted as Chief Medical Officer for an AIM-listed company. Currently, through his company, he is co-developing re-positioned and re-profiled medical products.
This document summarizes the findings of a study that assessed how aligned 25 countries' healthcare systems are with value-based healthcare (VBHC). The study evaluated countries based on 17 indicators across 4 domains: enabling context/policies, outcomes/costs measurement, integrated/patient-focused care, and outcome-based payment. Most countries are in the early stages of aligning with VBHC. While some countries like the US are making progress, fully implementing VBHC requires fundamental changes to entrenched fee-for-service models and will take time across all systems.
Policy Analysis SummaryHealth care policy can facilitate or i.docxtaishao1
Policy Analysis Summary
Health care policy can facilitate or impede the delivery of services. For the past several weeks, you have been engaging in an authentic activity by critically analyzing a specific health care policy and various aspects of the impact associated with its implementation. A critical step in the policy process is communicating your findings with others. This week, you will share information from your policy analysis and its implications.
To prepare:
Briefly summarize your policy analysis, focusing on the implications for clinical practice that may be most relevant or interesting for your colleagues. Include how evidence-based practice influenced the policy, policy options, or solutions.
By tomorrow 05/08/2018 10 pm, write a minimum of 250 words in APA format with at least 3 scholarly references from the list of required readings below. Include the level one headings as numbered below”
Post
a 2-paragraph succinct summary of your policy analysis paper.
Include at least two
of the options or solutions for addressing the policy and the resulting implications for nursing practice and health care consumers.
Required Readings
Bodenheimer, T., & Grumbach, K. (2016).
Understanding health policy: A clinical approach
(7th ed.). New York, NY: McGraw-Hill Medical.
Chapter 17, “Conclusion: Tensions and Challenges”
This chapter concludes with final thoughts on the challenge of providing quality health care and controlling health care costs. The solution is likely to be resolved only by a collaborative approach, involving all health care stakeholders, and by health professionals taking the lead.
Howard, J., Levy, F., Mareiniss, D. P., Craven, C. K., McCarthy, M., Epstein-Peterson, Z. D., & et al. (2010). New legal protections for reporting patient errors under the Patient Safety and Quality Improvement Act: A review of the medical literature and analysis.
Journal of Patient Safety, 6
(3), 147-152
.
The authors studied the dissemination of information on the Patient Safety and Quality Improvement Act (PSQIA), a federal act that affords protection to those reporting medical errors. They found medical literature to be inadequate in this regard, and as a result, medical personnel were uninformed on their legal protections. This lack of information has become a barrier to policy implementation.
Jacobson, N., Butterill, D., & Goering, P. (2003). Development of a framework for knowledge translation: Understanding user context.
Journal of Health Services Research & Policy, 8
(2), 94–99.
Lau, B., San Miguel, S., & Chow, J. (2010). Policy and clinical practice: Audit tools to measure adherence.
Renal Society of Australasia Journal, 6
(1), 36–40.
The authors study the compliance to renal-care policies by health care professionals. They conclude with the necessity for nurses to support evidence-based protocols as well as to obtain continuing education on new protocols.
...
The 2014 meeting of the International Occupational Medicine Society Collaborative (IOMSC) was held in London on June 28, 2014. Representatives from 17 countries discussed three key issues: communicating the value of occupational medicine, defining the role of occupational medicine societies, and educating practitioners. Meeting participants developed recommendations to refine messaging around occupational medicine's impact, develop a framework for societies' roles, and define core competencies. The next IOMSC meeting will be in 2015 in Washington D.C. to continue addressing global occupational medicine challenges.
National Institute of Health: Theory at a Glance, A Guide for Health Promotio...Zach Lukasiewicz
Introduction viii
Audience and Purpose 1
Contents 1
Part 1: Foundations of Theory in Health Promotion and Health Behavior 3
Why Is Theory Important to Health Promotion and Health Behavior Practice? 4
What Is Theory? 4
How Can Theory Help Plan Effective Programs? 4
Explanatory Theory and Change Theory 5
Fitting Theory to the Field of Practice 5
Using Theory to Address Health Issues in Diverse Populations 7
Part 2: Theories and Applications 9
The Ecological Perspective: A Multilevel, Interactive Approach 10
Theoretical Explanations of Three Levels of Influence 12
Individual or Intrapersonal Level 12
Health Belief Model 13
Stages of Change Model 15
Theory of Planned Behavior 16
Precaution Adoption Process Model 18
Interpersonal Level 19
Social Cognitive Theory 19
Community Level 22
Community Organization and Other Participatory Models 23
Diffusion of Innovations 27
Communication Theory 29
Media Effects 30
Agenda Setting 30
New Communication Technologies 31
Helping chronically ill or disabled people into work: what can we learn from ...StephenClayton11
This project has added to knowledge in five main areas:
It has mapped the range and types of policies and interventions that have been
implemented in Canada, Denmark, Norway, Sweden and the UK that may influence
employment chances for chronically ill and disabled people. By doing so it has added
to understanding about what has actually been tried in each country and what might be
considered in others.
It has refined a typology of the focussed interventions that have been identified, based
on the underlying programme logic of the intervention, which aids strategic thinking
about national efforts to help chronically ill and disabled people into work.
It has produced systematic reviews of the impact of the focussed interventions on the
employment chances of chronically ill and disabled people and demonstrated the use of
the typology in helping to interpret the results of the evaluations.
The project’s empirical analyses of individual-level data have identified how
chronically ill people from different socio-economic groups have fared in the labour
markets of the five countries over the past two decades. It has then tested these findings
against hypotheses about the impact of macro-level labour market policies on
chronically ill people to provide insights into the influence of the policy context.
The project has contributed to methodological development in evidence synthesis and
the evaluation of natural policy experiments. By studying a small number of countries
in great depth, we gained greater understanding of the policies and interventions that
have been tried in these countries to help chronically ill and disabled people into work,
against the backdrop of the wider labour market and macro-economic trends in those
countries. We then integrated evidence from the wider policy context into the findings
of systematic reviews of effectiveness of interventions, to advance interpretation of the
natural policy experiments that have been implemented in these countries.
Week 9 AssignmentContinue on with building your final applicatio.docxphilipnelson29183
The document provides guidance for a final paper on developing a health advocacy campaign. It instructs the student to combine their previous two papers on identifying a population health concern and approach to advocacy with an analysis of ethical considerations and applicable laws. This week, the student is asked to research relevant ethics provisions and lobbying laws and consider potential ethical dilemmas for their selected advocacy campaign. They will revise their previous papers and add a section addressing the new requirements to complete their final paper.
The document summarizes a health system assessment conducted in Guatemala by a team of USC MPH students. Through stakeholder interviews and a literature review, the team performed a SWOT analysis of Guatemala's health system. Key strengths identified included the ability to identify health problems and solutions and efforts to improve health. Weaknesses included lack of resources, disparities, and inadequate implementation of education programs. Opportunities included forming stakeholder coalitions and investing in human potential. Threats included organizational, integration, and human resource issues. The team provided recommendations to strengthen the system by forming coalitions, integrating traditional healers, addressing provider paradigms, and developing sound health policies.
Nurses as Leaders in Health Care ReformAs health care delivery in .docxgabriellabre8fr
Nurses as Leaders in Health Care Reform
As health care delivery in the United States continues to evolve, either through mandates, improved technologies and training, or other drivers, nurses remain at the forefront in facilitating the success of new initiatives. In 2010, the Institute of Medicine formed a committee of experts to address the following question: “What roles can nursing assume to address the increasing demand for safe, high-quality, and effective health care services?” In the final report of the committee,
The Future of Nursing: Leading Change, Advancing Health
, the authors stated:
This report offers recommendations that collectively serve as a blueprint to (1) ensure that nurses can practice to the full extent of their education and training, (2) improve nursing education, (3) provide opportunities for nurses to assume leadership positions and to serve as full partners in health care redesign and improvement efforts, and (4) improve data collection for workforce planning and policy making. (p. 10)
For this Discussion, you will focus on the research recommendations presented by the committee concerning the role of nurses as leaders. The committee members believe that answers to these research questions are needed to advance the profession of nursing and to further expand their role in health care reform and improvement.
To prepare:
Review Chapter 7 in
The Future of Nursing: Leading Change, Advancing Health
report provided in the Learning Resources. Focus on the information in Box 7.3, “Research Priorities for Transforming Nursing Leadership.”
Select one of the research priorities listed in Box 7.3 that is of particular interest to you and applicable to your career interests. Consider the benefits and challenges of researching and addressing this priority in nursing.
Using the Walden library, identify two to three current articles that address your selected research priority. Consider the current state of research efforts on this priority.
Reflect on how the research findings for your area of priority impact nurses as leaders in organizations and health care reform. Why is research on this priority important?
Post by Day 3
a description of the priority you selected and the benefits and challenges of further researching this area. Provide an overview of the articles you found (using appropriate APA citations) relating to this priority, and highlight any key findings. Explain how continued research in this area could strengthen the ability of nurses to lead in both individual organizations and as advocates of health care reform.
Readings
Knickman, J. R., & Kovner, A. R. (Eds.). (2015).
Health care delivery in the united states
(11th ed.). New York, NY: Springer Publishing.
Chapter 6, “Public Health: A Transformation for the 21st Century” (pp. 108-117)
This section of Chapter 6 outlines the roles of various government health agencies, as well as the powers and responsibilities of state versus federal institutions.
Chapter.
This resume summarizes the career and qualifications of Thomas R. MacGregor, Ph.D., a retired scientist with over 33 years of experience in the pharmaceutical industry. He held leadership roles in developing new drug applications and has a proven track record of successful drug development. Additionally, he has extensive experience in community involvement through organizations like Science Horizons and the American Chemical Society.
Running head PICOT STATEMENT 1PICOT STATEMENT 3PICOT .docxtoltonkendal
Running head: PICOT STATEMENT 1
PICOT STATEMENT 3
PICOT Statement: Childhood Obesity
Introduction
Childhood obesity is one of the emerging health problems that affect the American population. This disorder places children at a higher risk of suffering from preventable non-communicable chronic diseases, such as Type 2 diabetes, hypertension, and asthma (McGrath, 2017). Other challenges that affect children as a result of this disease include depression and sleep apnea. Obese children are often predisposed to become obese adults who suffer from many chronic diseases related to increased mortality rate of 40 percent. Obese children and adolescents tend to have more adverse health challenges compared to the counterparts with normal BMI. The task of addressing the chronic conditions related to childhood obesity is normally costly, with approximately $14 billion price tag and increasing (McGrath, 2017). Survey reports released by government agencies such as the National Conference of State Legislature, the total cost of obesity-associated nears $150 billion yearly, with taxpayers covering approximately sixty billion dollars. There is need to identify patterns that related to childhood obesity for professionals to seek better ways to address them. This PICOT statement evaluates childhood obesity in the United States.
PICOT Statement
Population
Childhood obesity is a major health concern in the United States and other parts of the world since the disease is increasing. In the US, obesity prevalence is highest among children aged from 6 to 11 years (Cheung et al. 2016). The disease has tripled among this age group from 4.2 percent to 15.3 percent from 1963 to 2012. In 2013, 16 percent of children in the country were categorized as obese. The prevalence was highest at ages of 12 to 19 years and lowest at ages of 2 to 5 years. In the last three decades, increased cases of obesity prevalence have been noted among children of all ages, although the differences in obesity prevalence have been recorded in terms of age, race, ethnicity, and gender (Cheung et al. 2016). In this respect, children from socioeconomically disadvantaged families and some racial and ethnic minorities experience the higher median score on obesity than the dominant white population. Higher obesity rates are often recorded among blacks and Hispanics compared to whites. For instance, a survey on girls in the Southwest revealed that the yearly cases of obesity stood at 4.5 percent among Blacks, 2 percent among Hispanics, and 0.7 percent among white girls aged from 13 to 17 years (Cheung et al. 2016). For low-income earners, American Indians rank highest at 6.3 percent, followed closely by Hispanics at 5.5 percent.
Intervention
Evidence-based interventions that seek to reduce childhood obesity incidences in the country should target two major areas: prevention and treatment. High-quality RCT has been proven as one of the most effective preventative intervention, especially ...
Maria Dj Keiser is a FINRA registered Compliance Analyst with over 30 years of experience in administrative, operational, and compliance roles. She has expertise in analyzing customer and firm risk, educating staff, and resolving complex issues. Her most recent roles include working as a Compliance Advisor for Lumen Legal and as a Compliance Analyst for Investment Professional Inc., where she conducted suitability reviews and ensured compliance. She aims to enhance business processes and optimize profitability through leadership, problem solving, and implementing revenue-generating activities.
Sudhir hadoop and Data warehousing resume Sudhir Saxena
Overall 5.8 Years of Professional IT experience in Data Warehousing and Business Intelligence.
Having one year onsite experience in Mexico and USA with USAA Client, USA.
Having good Knowledge in Bigdata, Hadoop, Pig, Hive, Sqoop, Hbase, Python, Spark, Scala.
New Vision Youth Services seeks to help the over 500 foster youth who age out of the foster care system in Virginia each year. These youth face numerous challenges as they transition to independent living without a family support system. New Vision provides services like life skills training, education assistance, job readiness support, and health information to prepare foster youth for adulthood. A key program connects college-aged former foster youth with mentors who serve as role models and help them navigate challenges like choosing housing and transportation. The mentors aim to fill the gap left by the lack of family for these at-risk young adults.
This document is a resume for Vajiha Wadwan, a senior systems engineer with 3 years of experience in application development in the banking and finance domain. She has experience with programming languages like Perl, Shell Scripting, C, C++, Pig, Hive, and databases like DB2, Netezza. She has worked on projects involving marketing campaigns, credit card data analytics, and migration from AIX to Linux. Her roles included developing code, testing, documentation, and coordinating with teams. She has a Bachelor's degree in Information Technology.
As an accomplished developer with over 5 years’ experience in the field of Zope/Plone 3(expert), 4(expert) anf 5(intermediate)/Python. I am well positioned to join your company and make an immediate positive impression. My key areas of expertise include, but are not limited to the following:
· A solid background in Plone CMS, Zope and Python.
· Good knowledge in Python 2.X, Linux, Unix OS, MySQL, PostgreSQL , CSS3, HTML, JavaScript, Ajax, J Query and J SON, XML parsing etc.
This document provides a summary of the candidate's background and qualifications. The candidate has over 6 years of experience in test design, execution, and as a technical lead. They have a Bachelor's degree in Electronics and Telecommunications Engineering. Their areas of expertise include requirement analysis, test planning, Android and cloud application testing, connectivity testing, and tools like Appium and JMeter. They have led several projects involving testing of IMS protocols, MirrorLink, clinical applications, and FOTA systems.
Our client in Amsterdam is seeking a front-end developer to work on their communication cloud services and intelligent applications using machine learning. As part of an agile development team, the ideal candidate will translate designs into code, ensure cross-browser compatibility, and optimize applications for speed and scalability. Responsibilities include collaborating with others to design new solutions and troubleshoot customer issues. The position offers a competitive salary and benefits package in a diverse, fast-paced work environment.
Vinay Rohilla is a software engineer with 3.8 years of experience seeking a middle-level role in software testing and quality assurance. He has a B.Tech in Information Technology and is currently working at HCL Technologies. He has experience in manual testing, test planning, quality assurance processes, agile methodology, and working with various testing methodologies. At HCL, his responsibilities include maintaining testing logs, writing test cases, guiding junior team members, and ensuring quality assurance standards are met.
This document is a resume for Aneesh Mohan detailing his background and experience. It summarizes that he has over 5 years of experience in information technology in India and the Gulf region. He is seeking a job in IT where he can apply his skills and experience in software, hardware, databases, systems, and networks. The resume lists his technical skills and qualifications and provides details on his past roles and responsibilities at various companies.
S. Ramkumar is a software developer with over 5 years of experience in Python, Perl, and Unix shell scripting. He has worked on projects for clients like Verizon and Morgan Stanley, developing scripts for automation, data processing, reporting and more. His skills include writing scripts for tasks like system monitoring, file transfer, database integration, and report generation. He is looking for a challenging position that utilizes his programming and problem-solving abilities.
Tony Lockett has over 25 years of experience in the pharmaceutical and medical devices industry. He has acted as a consultant advising clients on regulatory and clinical strategies, and has also acted as Chief Medical Officer for an AIM-listed company. Currently, through his company, he is co-developing re-positioned and re-profiled medical products.
This document summarizes the findings of a study that assessed how aligned 25 countries' healthcare systems are with value-based healthcare (VBHC). The study evaluated countries based on 17 indicators across 4 domains: enabling context/policies, outcomes/costs measurement, integrated/patient-focused care, and outcome-based payment. Most countries are in the early stages of aligning with VBHC. While some countries like the US are making progress, fully implementing VBHC requires fundamental changes to entrenched fee-for-service models and will take time across all systems.
Policy Analysis SummaryHealth care policy can facilitate or i.docxtaishao1
Policy Analysis Summary
Health care policy can facilitate or impede the delivery of services. For the past several weeks, you have been engaging in an authentic activity by critically analyzing a specific health care policy and various aspects of the impact associated with its implementation. A critical step in the policy process is communicating your findings with others. This week, you will share information from your policy analysis and its implications.
To prepare:
Briefly summarize your policy analysis, focusing on the implications for clinical practice that may be most relevant or interesting for your colleagues. Include how evidence-based practice influenced the policy, policy options, or solutions.
By tomorrow 05/08/2018 10 pm, write a minimum of 250 words in APA format with at least 3 scholarly references from the list of required readings below. Include the level one headings as numbered below”
Post
a 2-paragraph succinct summary of your policy analysis paper.
Include at least two
of the options or solutions for addressing the policy and the resulting implications for nursing practice and health care consumers.
Required Readings
Bodenheimer, T., & Grumbach, K. (2016).
Understanding health policy: A clinical approach
(7th ed.). New York, NY: McGraw-Hill Medical.
Chapter 17, “Conclusion: Tensions and Challenges”
This chapter concludes with final thoughts on the challenge of providing quality health care and controlling health care costs. The solution is likely to be resolved only by a collaborative approach, involving all health care stakeholders, and by health professionals taking the lead.
Howard, J., Levy, F., Mareiniss, D. P., Craven, C. K., McCarthy, M., Epstein-Peterson, Z. D., & et al. (2010). New legal protections for reporting patient errors under the Patient Safety and Quality Improvement Act: A review of the medical literature and analysis.
Journal of Patient Safety, 6
(3), 147-152
.
The authors studied the dissemination of information on the Patient Safety and Quality Improvement Act (PSQIA), a federal act that affords protection to those reporting medical errors. They found medical literature to be inadequate in this regard, and as a result, medical personnel were uninformed on their legal protections. This lack of information has become a barrier to policy implementation.
Jacobson, N., Butterill, D., & Goering, P. (2003). Development of a framework for knowledge translation: Understanding user context.
Journal of Health Services Research & Policy, 8
(2), 94–99.
Lau, B., San Miguel, S., & Chow, J. (2010). Policy and clinical practice: Audit tools to measure adherence.
Renal Society of Australasia Journal, 6
(1), 36–40.
The authors study the compliance to renal-care policies by health care professionals. They conclude with the necessity for nurses to support evidence-based protocols as well as to obtain continuing education on new protocols.
...
The 2014 meeting of the International Occupational Medicine Society Collaborative (IOMSC) was held in London on June 28, 2014. Representatives from 17 countries discussed three key issues: communicating the value of occupational medicine, defining the role of occupational medicine societies, and educating practitioners. Meeting participants developed recommendations to refine messaging around occupational medicine's impact, develop a framework for societies' roles, and define core competencies. The next IOMSC meeting will be in 2015 in Washington D.C. to continue addressing global occupational medicine challenges.
National Institute of Health: Theory at a Glance, A Guide for Health Promotio...Zach Lukasiewicz
Introduction viii
Audience and Purpose 1
Contents 1
Part 1: Foundations of Theory in Health Promotion and Health Behavior 3
Why Is Theory Important to Health Promotion and Health Behavior Practice? 4
What Is Theory? 4
How Can Theory Help Plan Effective Programs? 4
Explanatory Theory and Change Theory 5
Fitting Theory to the Field of Practice 5
Using Theory to Address Health Issues in Diverse Populations 7
Part 2: Theories and Applications 9
The Ecological Perspective: A Multilevel, Interactive Approach 10
Theoretical Explanations of Three Levels of Influence 12
Individual or Intrapersonal Level 12
Health Belief Model 13
Stages of Change Model 15
Theory of Planned Behavior 16
Precaution Adoption Process Model 18
Interpersonal Level 19
Social Cognitive Theory 19
Community Level 22
Community Organization and Other Participatory Models 23
Diffusion of Innovations 27
Communication Theory 29
Media Effects 30
Agenda Setting 30
New Communication Technologies 31
Helping chronically ill or disabled people into work: what can we learn from ...StephenClayton11
This project has added to knowledge in five main areas:
It has mapped the range and types of policies and interventions that have been
implemented in Canada, Denmark, Norway, Sweden and the UK that may influence
employment chances for chronically ill and disabled people. By doing so it has added
to understanding about what has actually been tried in each country and what might be
considered in others.
It has refined a typology of the focussed interventions that have been identified, based
on the underlying programme logic of the intervention, which aids strategic thinking
about national efforts to help chronically ill and disabled people into work.
It has produced systematic reviews of the impact of the focussed interventions on the
employment chances of chronically ill and disabled people and demonstrated the use of
the typology in helping to interpret the results of the evaluations.
The project’s empirical analyses of individual-level data have identified how
chronically ill people from different socio-economic groups have fared in the labour
markets of the five countries over the past two decades. It has then tested these findings
against hypotheses about the impact of macro-level labour market policies on
chronically ill people to provide insights into the influence of the policy context.
The project has contributed to methodological development in evidence synthesis and
the evaluation of natural policy experiments. By studying a small number of countries
in great depth, we gained greater understanding of the policies and interventions that
have been tried in these countries to help chronically ill and disabled people into work,
against the backdrop of the wider labour market and macro-economic trends in those
countries. We then integrated evidence from the wider policy context into the findings
of systematic reviews of effectiveness of interventions, to advance interpretation of the
natural policy experiments that have been implemented in these countries.
Week 9 AssignmentContinue on with building your final applicatio.docxphilipnelson29183
The document provides guidance for a final paper on developing a health advocacy campaign. It instructs the student to combine their previous two papers on identifying a population health concern and approach to advocacy with an analysis of ethical considerations and applicable laws. This week, the student is asked to research relevant ethics provisions and lobbying laws and consider potential ethical dilemmas for their selected advocacy campaign. They will revise their previous papers and add a section addressing the new requirements to complete their final paper.
The document summarizes a health system assessment conducted in Guatemala by a team of USC MPH students. Through stakeholder interviews and a literature review, the team performed a SWOT analysis of Guatemala's health system. Key strengths identified included the ability to identify health problems and solutions and efforts to improve health. Weaknesses included lack of resources, disparities, and inadequate implementation of education programs. Opportunities included forming stakeholder coalitions and investing in human potential. Threats included organizational, integration, and human resource issues. The team provided recommendations to strengthen the system by forming coalitions, integrating traditional healers, addressing provider paradigms, and developing sound health policies.
Nurses as Leaders in Health Care ReformAs health care delivery in .docxgabriellabre8fr
Nurses as Leaders in Health Care Reform
As health care delivery in the United States continues to evolve, either through mandates, improved technologies and training, or other drivers, nurses remain at the forefront in facilitating the success of new initiatives. In 2010, the Institute of Medicine formed a committee of experts to address the following question: “What roles can nursing assume to address the increasing demand for safe, high-quality, and effective health care services?” In the final report of the committee,
The Future of Nursing: Leading Change, Advancing Health
, the authors stated:
This report offers recommendations that collectively serve as a blueprint to (1) ensure that nurses can practice to the full extent of their education and training, (2) improve nursing education, (3) provide opportunities for nurses to assume leadership positions and to serve as full partners in health care redesign and improvement efforts, and (4) improve data collection for workforce planning and policy making. (p. 10)
For this Discussion, you will focus on the research recommendations presented by the committee concerning the role of nurses as leaders. The committee members believe that answers to these research questions are needed to advance the profession of nursing and to further expand their role in health care reform and improvement.
To prepare:
Review Chapter 7 in
The Future of Nursing: Leading Change, Advancing Health
report provided in the Learning Resources. Focus on the information in Box 7.3, “Research Priorities for Transforming Nursing Leadership.”
Select one of the research priorities listed in Box 7.3 that is of particular interest to you and applicable to your career interests. Consider the benefits and challenges of researching and addressing this priority in nursing.
Using the Walden library, identify two to three current articles that address your selected research priority. Consider the current state of research efforts on this priority.
Reflect on how the research findings for your area of priority impact nurses as leaders in organizations and health care reform. Why is research on this priority important?
Post by Day 3
a description of the priority you selected and the benefits and challenges of further researching this area. Provide an overview of the articles you found (using appropriate APA citations) relating to this priority, and highlight any key findings. Explain how continued research in this area could strengthen the ability of nurses to lead in both individual organizations and as advocates of health care reform.
Readings
Knickman, J. R., & Kovner, A. R. (Eds.). (2015).
Health care delivery in the united states
(11th ed.). New York, NY: Springer Publishing.
Chapter 6, “Public Health: A Transformation for the 21st Century” (pp. 108-117)
This section of Chapter 6 outlines the roles of various government health agencies, as well as the powers and responsibilities of state versus federal institutions.
Chapter.
This resume summarizes the career and qualifications of Thomas R. MacGregor, Ph.D., a retired scientist with over 33 years of experience in the pharmaceutical industry. He held leadership roles in developing new drug applications and has a proven track record of successful drug development. Additionally, he has extensive experience in community involvement through organizations like Science Horizons and the American Chemical Society.
Running head PICOT STATEMENT 1PICOT STATEMENT 3PICOT .docxtoltonkendal
Running head: PICOT STATEMENT 1
PICOT STATEMENT 3
PICOT Statement: Childhood Obesity
Introduction
Childhood obesity is one of the emerging health problems that affect the American population. This disorder places children at a higher risk of suffering from preventable non-communicable chronic diseases, such as Type 2 diabetes, hypertension, and asthma (McGrath, 2017). Other challenges that affect children as a result of this disease include depression and sleep apnea. Obese children are often predisposed to become obese adults who suffer from many chronic diseases related to increased mortality rate of 40 percent. Obese children and adolescents tend to have more adverse health challenges compared to the counterparts with normal BMI. The task of addressing the chronic conditions related to childhood obesity is normally costly, with approximately $14 billion price tag and increasing (McGrath, 2017). Survey reports released by government agencies such as the National Conference of State Legislature, the total cost of obesity-associated nears $150 billion yearly, with taxpayers covering approximately sixty billion dollars. There is need to identify patterns that related to childhood obesity for professionals to seek better ways to address them. This PICOT statement evaluates childhood obesity in the United States.
PICOT Statement
Population
Childhood obesity is a major health concern in the United States and other parts of the world since the disease is increasing. In the US, obesity prevalence is highest among children aged from 6 to 11 years (Cheung et al. 2016). The disease has tripled among this age group from 4.2 percent to 15.3 percent from 1963 to 2012. In 2013, 16 percent of children in the country were categorized as obese. The prevalence was highest at ages of 12 to 19 years and lowest at ages of 2 to 5 years. In the last three decades, increased cases of obesity prevalence have been noted among children of all ages, although the differences in obesity prevalence have been recorded in terms of age, race, ethnicity, and gender (Cheung et al. 2016). In this respect, children from socioeconomically disadvantaged families and some racial and ethnic minorities experience the higher median score on obesity than the dominant white population. Higher obesity rates are often recorded among blacks and Hispanics compared to whites. For instance, a survey on girls in the Southwest revealed that the yearly cases of obesity stood at 4.5 percent among Blacks, 2 percent among Hispanics, and 0.7 percent among white girls aged from 13 to 17 years (Cheung et al. 2016). For low-income earners, American Indians rank highest at 6.3 percent, followed closely by Hispanics at 5.5 percent.
Intervention
Evidence-based interventions that seek to reduce childhood obesity incidences in the country should target two major areas: prevention and treatment. High-quality RCT has been proven as one of the most effective preventative intervention, especially ...
This document summarizes the development of health communication as a field over the past 25 years. It begins by describing the Stanford Heart Disease Prevention Program in 1971 as a seminal project that applied communication strategies to promote preventive health behaviors. Since then, the field has grown substantially, establishing university centers, securing research funding, and contributing to more effective health promotion campaigns. Key strategies discussed include social marketing, which applies commercial marketing approaches to social causes like health, and audience segmentation to target messages. The document traces how approaches from early projects have been applied more broadly to address other health issues.
This document provides an overview of the book "Health Promotion Theory". It discusses why studying health promotion theory is important for public health practitioners to develop effective interventions. The book is divided into four sections that cover: 1) the philosophy and theories of health promotion, 2) epidemiology, politics and ethics, 3) public policy, and 4) implementing health promotion. The overview previews the key topics and chapters in each section to help readers understand the scope and structure of the book.
Running head MAYO CLINIC1Mayo Clinic2.docxcowinhelen
Running head: MAYO CLINIC 1
Mayo Clinic 2
Mayo Clinic
Kurtis Gray
HA499
Kaplan University
16 February 2016
Mayo clinical is a not-for-profit organization based in Rochester, Minnesota. It is one of the largest medical practice and medical research group in the world and has employed more than 3,800 physicians and over 50,000 scientists allied to the staff. It is present in the United States metropolitan areas and has the core values of providing patient care practice represented by the central shield. Patient care has been one of the first priorities of this organization and it has been able to offer highly specialized care hence most of the population in this medical facility are referrals from smaller clinics and other hospitals from across the United States (Ludwig, Viggiano, Mcgill & Oh, 1980).
The rationale behind the selection of this organization is that, this clinic has greatly contributed to understanding various disease processes and has been able to provide best clinical practices to patients. It has also helped with the establishment of current residency education system in the institution. It has developed more innovations to help researchers to actually study the interactions between human health and the indoor spaces. Most researchers in this health institution have actually improved patient care hence translating discoveries into therapies which have exponentially improved the lives of individuals in the area (Fontana, Sanderson, Taylor, Woolner, Miller, Muhm & Uhlenhopp, 1984).
Mayo clinic has outlined its mission to inspire and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research. The primary value of this clinic is that the patient comes first. The management of this clinic has also been able to enable equal treatment of everyone within the diverse communities including patients, their families with great dignity. It has the compassion to provide the best care to patients with sensitivity and empathy. This hospital has been very successful since it has been able to adhere to the highest standards of professionalism ethics and personal responsibility.
It has also enabled the healing process to actually respect the spiritual and physical needs of the patients and also to make sure that the teamwork within the working place creates much excellence in the working environment. Mayo clinic has also been able to deliver the best outcomes through the dedication of all team members in this hospital. Various innovations have also energized Mayo clinic and has greatly contributes to enhancement of people’s lives through creation of ideas as well as various unique talents of all employees in this organization Ludwig (Viggiano, Mcgill, & Oh, 1980).
Mayo clinic’s success is based upon training, team work compensation and employees who improve the general health care system of their clients. Putting patient’s interest first is one ...
José Ferraz Nunes has over 40 years of experience in teaching, researching, and consulting in health economics. He has taught at several universities in Sweden, Portugal, and Australia. His research focuses on economic evaluations, cost analyses, and efficiency assessments in healthcare. He has published numerous articles and books on topics like cost-effectiveness analysis, health as capital, and the economic burden of conditions like stroke. He has consulted for organizations on projects evaluating costs and impacts of interventions in areas like rehabilitation, transportation, cancer treatment, and stroke care.
Assignment 3 Policy Analysis Paper In previous Discussion.docxluearsome
Assignment 3: Policy Analysis Paper
In previous Discussions and Assignments, you have examined various aspects of the policy process: exploring the unintended consequences of policies, agenda setting, and analyzing policy recommendations. In this Assignment, you will have the opportunity to further develop your analysis skills by working through the policy analysis process. To be an effective agent for social change, you must be able to logically and critically analyze policy from multiple perspectives and contexts and then present your insights in a succinct and professional manner. This exercise will afford such an experience.
For this Assignment, you will examine a particular policy of interest to you (perhaps the one you selected for this week's Discussion) and apply a policy analysis framework to understand the impact associated with the implementation of the policy. You will then develop a policy analysis paper, which is due day 5 of Week 11. This paper will also serve as your Major Assessment for this course.
To prepare:
Select a health care policy and a policy analysis framework to utilize for this Assignment. You may use the policy and framework you identified in this week’s Discussion or change your selection.
To complete:
Write an 8- to 10-page analysis paper (including references) in which you succinctly address the following:
1) An introduction
2)
Part 1: Define the policy issue.
a) How is the issue affecting the policy arena?
b) What are the current politics of the issue?
c) At what level in the policy making process is the issue?
3)
Part 2: Apply a policy analysis framework to explore the issue using the following contexts:
a) Social
b) Ethical
c) Legal
d) Historical
e) Financial/economic
f) Theoretical underpinnings of the policy
Include in this section:
a) Who are the stakeholders of interest?
b) Is there a nursing policy/position statement on this health care issue? If so, who developed it?
4)
Part 3: Policy options/solutions
a) What are the policy options/solutions for addressing the issue? Include at least three levels of options/solutions: no change; partial change; radical change or maximum change.
b) What are the theoretical underpinnings of the policy options/solutions?
c) What are the health advocacy aspects and leadership requirements of each option?
d) How does each option/solution provide an opportunity or need for inter-professional collaboration?
e) What are the pros and cons of each suggested change? Include the cost benefits, effectiveness, and efficiency of each option along with the utility and feasibility of each option.
5)
Part 4: Building Consensus
a) Outline a plan for building consensus around your recommended option/solution for solving the policy issue.
6) A Conclusion
7)
Part 5: References
a) Limit your references so this section is no more than 2 pages.
Your written assignments must follow APA guidelines. Be sure to support your work with ...
This document provides an overview of health promotion for nurses. It discusses how health promotion has become an increasingly important part of the nurse's role according to health policies and the shifting focus of nursing from disease to health. The document outlines some key health promotion frameworks and approaches, including identifying three principal ways nurses can approach health promotion: as a behavior change agent, empowerment facilitator, and strategic practitioner. It also discusses how health promotion interventions can be evaluated for their aims, processes, impacts and outcomes within each of these models. Finally, the document provides context on the historical development of health promotion and how frameworks have emerged in response.
Leading change in healthcare- thesis_Mulondo_160601jerry mulondo
This document summarizes Jerry Mulondo's master's thesis which explored leadership approaches associated with positive change in healthcare. The thesis used narrative analysis of interviews with 19 physician leaders in Sweden. Five major themes were identified: an evidence-informed and problem-focused approach; driving goals from the front; leaders as facilitators; vision guiding leadership; and principles guiding leadership. These themes were linked to leadership theories. The study found that leadership development programs should draw from various leadership theories and develop capabilities for data-informed change processes. Further research is needed on physician leadership and the factors affecting leadership style choices in different healthcare settings.
Advocating Through Policy Empire Essays.pdfsdfghj21
Nurses should engage in advocacy efforts to improve health and nursing practice through involvement in the policy process at various levels of government. There are opportunities for nurses to get involved regardless of time constraints. Successful policymaking requires collaboration between stakeholders. Nurses can become leaders and respected members of interprofessional healthcare teams by participating in the policy process.
Required MaterialLawler, E. E. (2017). Reinventing talent manage.docxkellet1
Required Material
Lawler, E. E. (2017). Reinventing talent management: Principles and practices for the new world of work. Retrieved from ProQuest, Ebook Central in the Trident Online Library.
RBL Group. (2015). Overview of the Competency Model [Video file]. Retrieved from https://www.youtube.com/watch?v=9BdjdgySzxE.
Sanghi, S. (2016). Chapter 1: Introduction to competency mapping. In The Handbook of Competency Mapping: Understanding, Designing, and Implementing Competency Models in Organizations (pp. 1-25). Thousand Oaks, California: Sage Publications. Retrieved from EBSCO in the Trident Online Library.
Sanghi, S. (2016). Chapter 3: Competency-based applications. The Handbook of Competency Mapping: Understanding, Designing, and Implementing Competency Models in Organizations (pp. 49-76). Thousand Oaks, California: Sage Publications. Retrieved from EBSCO in the Trident Online Library.
(If you are interested in learning more about competency models and mapping, read other chapters in this book.)
RESEARCH - EDUCATION
Improving prescribing practices: A pharmacist-led educational
intervention for nurse practitioner students
Jennifer A. Sabatino, PharmD, BCACP (Clinical Pharmacist)1, Maria C. Pruchnicki, PharmD, BCPS, BCACP, CLS
(Associate Professor)2, Alexa M. Sevin, PharmD, BCACP (Assistant Professor)2, Elizabeth Barker, PhD, CNP,
FAANP, FACHE, FNAP, FAAN, FNP-BC (Professor Emeritus of Clinical Nursing)3, Christopher G. Green, PharmD
(Specialty Practice Pharmacist)4, & Kyle Porter, MAS (Senior Consulting Research Statistician)5
1Department of Pharmacy, Memorial Hospital Medication Therapies Center, Marysville, Ohio
2Division of Pharmacy Practice and Science, The Ohio State University College of Pharmacy, Columbus, Ohio
3College of Nursing, The Ohio State University, Columbus, Ohio
4Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio
5Center for Biostatistics, The Ohio State University, Columbus, Ohio
Keywords
Pharmacotherapy; education; prescriptions;
students; pharmacists; nurse practitioner;
advanced practice nurse.
Correspondence
Maria C. Pruchnicki, PharmD, BCPS, BCACP,
CLS, Division of Pharmacy Practice and Science,
The Ohio State University College of Pharmacy,
500 West 12th Avenue, Columbus, OH 43210.
Tel: 614-292-1363; Fax: 614-292-1335; E-mail:
[email protected]
Received: 22 May 2016;
accepted: 6 January 2017
doi: 10.1002/2327-6924.12446
Previous presentations: Poster presentation at
the American Pharmacists Association Annual
Meeting, March 2014, Orlando, Florida.
Encore poster presentation at the Ohio
Pharmacists Association 136th Annual Meeting,
April 2014, Columbus, Ohio.
Podium presentation at the Ohio Pharmacy
Resident Conference, May 2014, Ada, Ohio.
Encore podium presentation at the Celebration
of Educational Scholarship “Advances in Health
Sciences Education” at The Ohio State
University College of Medicine, November
2014, Columbus, Ohio.
Encore poster presenta.
Required MaterialLawler, E. E. (2017). Reinventing talent manage.docx
PCLProfileCVNovemberl2015
1. BIOSKETCH AND CURRICULUM VITAE
November 2015
PAUL C. LANGLEY
B.Sc. (Econ). M.A., Ph.D.
Dr Paul Langley is a professional economist. His undergraduate training was in the UK,
University of Hull (B. Sc [Econ]) with postgraduate training in Canada at Carleton University
(M.A.) and Queen’s University (Ph.D.). Dr Langley has taught in the UK (University of
Lancaster) and in Australia (La Trobe University) with visiting appointments at Carleton
University, the University of Ohio and the University of California (Irvine). Although initially
focusing on labor economics, Dr Langley moved into health economics – specifically the
economic evaluation of pharmaceutical products - in the early 1990s. The impetus for this move
was the decision, in 1992, by the Australian Department of Health to require companies seeking
formulary approval for new products to make a cost-effectiveness case in order to justify the unit
cost of the product and its formulary listing.
Following this decision by the Australian authorities, a number of other countries (Canada, New
Zealand) began developing their own formulary submission guidelines and evidentiary and
analytical standards for economic evaluations emerged. Although guidelines had not yet been
introduced within the United States, there was considerable interest among both drug
manufacturers and academic health economics groups in the emergence of guidelines
requirements and in the need to improve understanding of the new evaluative techniques as they
applied to a range of new products and disease areas. As a result of his early work in Australia,
Dr Langley was appointed Associate Professor at the University of Arizona (College of
Pharmacy; Center for Pharmaceutical Economics) in July 1994 and moved from Australia to the
United States. Following a successful three years at Arizona (where Dr Langley authored some
20 publications in this area and managed a number of significant research projects), Dr Langley
was appointed Professor at the University of Colorado (School of Pharmacy, University of
Colorado Health Sciences Center) in July 1997. One of Dr Langley’s tasks at Colorado was to
establish a Center for Pharmaceutical Economics. Following a successful two years at Colorado,
Dr Langley moved to 3M Pharmaceuticals in September 1999 (through July 2005) as US and
International Manager, Health Economics with worldwide responsibilities for economic
evaluations as they apply to drug development, reimbursement and post-market entry support.
A major focus of Dr Langley’s activities both at universities and as a consultant has been in the
development of training programs in pharmaceutical economics, health economics and the
burden of illness. At the University Of Arizona Dr Langley was instrumental in establishing the
Certificate Program in Pharmacoeconomics in the mid-1990s. A similar program was developed
at the University of Colorado. Dr Langley has developed packages for distance learning in
pharmaceutical economics as well as general and disease specific training programs for
healthcare systems and pharmaceutical companies.
1
2. Since leaving 3M pharmaceuticals, Dr Langley has managed his consulting company, Maimon
Research LLC, undertaking a number of consultancy projects in major disease areas as well as
advising on document management and minimum evidentiary standards for drug development
decisions and reimbursement.
One of the major forums for developing and publicizing new ideas is through management
monographs. Dr Langley has published a number of these: Pharmacoeconomics: Achieving Gold
Standards (London: Financial Times Healthcare, 1997); Disease Management Outcomes
(London: Financial Times Healthcare, 1998). Dr Langley’s management monograph is Health
Economics in the Drug Life Cycle (London: Urch Publishing 2002) established critical paths for
drug development to incorporate health outcomes activities over the drug life cycle.
Dr Langley has extensive experience in working with pharmacy and therapeutics committees in
drug evaluation. He was the first author to publish guidelines for formulary evaluation of
pharmaceuticals in the US (Foundation Health of California, 1996; Blue Cross and Blue Shield
of Colorado and Nevada 1999) and was instrumental in developing the guidelines recommended
by the Academy of Managed Care Pharmacy. Dr Langley has strong links with managed care
and is often asked to speak at their conferences. Needless to say, Dr Langley has extensive
experience in pharmacoeconomics and in the wider area of health technology assessment. He
brings a global perspective to this area. Dr Langley has pioneered the notion of document
management and dossier development to support a product through drug development, market
entry and the balance of the product life cycle. Such a dossier brings together all the relevant
components of the health technology assessment case for a product (epidemiology, comparator
clinical assessments, cost-effective models, system impact models) to meet reimbursement
requirements for market segments with the US and at national levels globally. At the same time
Dr Langley is advising pharmaceutical companies on the most appropriate way to develop an
evidentiary base to support value proposition for clinical, cost-effectiveness and budget impact
claims. Notably for the US, Canada, the EU and Australia/New Zealand.
To support dossier development and to provide a single-source framework for drug development
and market access support, Maimon Research has developed a Global Value Dossier software
package. This package allows the creation of text, the preparation of formulary submission
documentation through templates, document storage and URL links to references and websites.
This package has been adopted by a number of pharmaceutical companies over the past 6 years.
A demonstration version of the package is available and, in any long term relationship with
either a consultant group of a drug company, licensing and training support are available.
Dr Langley has published in the area of population health, focusing on the societal burden of
pain and pain co-morbidities. Three aspects of disease burden are considered: (i) health related
quality of life and self-reported health status; (ii) employment status, absenteeism and
presenteeism; and (iii) healthcare resource utilization. Ten papers have been published covering
the UK, France, Germany, Spain, Italy and China.
Most recently (November 2015) Dr Langley was invited to organize a special supplement for the
Journal of Medical Economics on ‘The status of modeled claims in pharmacoeconomics’. This
2
3. focuses on the credibility of cost-outcomes claims and the importance of developing testable
claims to support formulary submissions and ongoing disease area and therapeutic class reviews.
Dr Langley is currently Director, Maimon Research LLC, a health economics consulting and
research company based in Tucson, AZ. Dr Langley is also Adjunct Professor, Graduate School,
College of Pharmacy, University of Minnesota.
Contact: Maimon Research LLC
5061 N Apache Hills Trail
Tucson AZ 85750.
Email: Langley@maimonresearch.com
Tel: (520) 577-0436
3
4. PUBLICATIONS
Langley PC. The spatial allocation of migrants in England and Wales. Scottish Journal
of Political Economy. 1974;21(3): 259-77. Reprinted in J.E.King, ed., Readings in
Labor Economics. Oxford University Press, 1980
Langley PC. Interregional migration and economy opportunity: Australia 1966-71.
Economic Record 1977;53(1):61-69
Langley PC. Labor market segmentation: A reconsideration. Industrial and Labor
Relations Review 1978;32(1):86-92
Langley PC. The private gains to long-distance migration in the United States. Economic
Journal. 1979;89:120-26.
Lipsey RG, Mahoney DM, Langley PC. Positive Economics for Australian Students,
Weidenfeld and Nicholson, London (1st ed., 1981, 850pp; 2nd ed., 1985): A first year
economics text based on RG Lipsey's, Positive Economics (UK edition), and RG Lipsey
and PO Steiner's, Economics (US edition). This became the largest selling first year
university economics text in Australia for 4 consecutive years.
Langley PC, Peterson HM. "Earnings and Work Experience in Australian Country
Towns." in: Chapman BJ, Isaac JE, Niland JR (Eds), Australian Labor Economics
Readings, 3rd ed., 1985.
Langley PC. "The Determinants of Labor Force Migration in Australia, 1966-71," in
Chapman BJ, Isaac JE, Niland JR (Eds), Australian Labor Economics Reading, 3rd ed.,
1985.
Langley PC. Employment and Occupational Trends in Victoria: 1985-2000 TAFE
National Center for Research and Development, Adelaide, 1985.
Langley PC, Luscombe R. Employment Projections for Metropolitan Melbourne,
Victoria, Ministry of Planning and Environment, 1987.
Langley PC. (Principal consultant and project manager) Workcare: A Strategy for Reform
within the Schools Division. Victoria, Ministry of Education, 1987 (A Report to a Select
Committee of the Parliament of Victoria).
Langley PC. Evaluating the economic and social impact of vocational rehabilitation
programs in Victoria. Performance Improvement Quarterly 1989; 2(2): 30-46.
Langley PC. The role of pharmacoeconomic guidelines for formulary approval: The
Australian experience. Clinical Therapeutics 1993;15(6): 1154-1176.
Langley PC. Outcomes research and modeling therapeutic interventions. Clinical
4
5. Therapeutics 1994; 16(3): 538-562.
Ortmeier BG, Sauer KA, Langley PC, Bealmear BK. A cost-benefit analysis of four
hormonal contraceptive methods. Clinical Therapeutics 1994; 16(4): 707-713.
Langley PC. Therapy evaluation, patient distribution, and cost-outcomes ratios. Clinical
Therapeutics 1995, 17(2): 341-347.
Langley PC. Pharmacoeconomic evaluation and the modeling of disease interventions.
Pharmaceutical News 1995; 2(4).
Langley PC. Comment: Substantiation in pharmacoeconomic evaluations. The Annals
of Pharmacotherapy 1995; 29(9): 942-943
Langley PC. Pharmacoeconomics and the quality of decision making by pharmacy and
therapeutics committees. American Journal of Health-System Pharmacy 1995; 52(S3):
S26-S28.
Langley PC. Cost Effectiveness profiles with an expanding treatment population.
Clinical Therapeutics 1995; 17(6); 1207-1212.
Armstrong EP, Langley PC. Disease management programs. American Journal of
Health-System Pharmacy 1996; 53: 53-58.
Langley PC. The November 1995 revised Australian guidelines for the economic
evaluation of pharmaceuticals. PharmacoEconomics. 1996; 9(4): 341-352.
Langley PC. Cost effectiveness and the allocation of therapies in a treating population.
PharmacoEconomics 1996; 10(1): 93-98.
Langley PC. Langley-Hawthorne CE, Martin RE, Armstrong EP. Establishing the basis
for successful disease management contracting. American Journal of Managed Care
1996; 2(8): 1099-1108.
Langley PC, Sullivan SD. Pharmacoeconomic evaluation: Guidelines for drug
purchasers. Journal of Managed Care Pharmacy 1996; 2(6): 671-677.
Langley PC. Outcomes and costs in health care interventions: Implications for pharmacy
practice. The California Journal of Health-System Pharmacy; September 1996.
Langley PC. Pharmacoeconomic Guidelines: Australia and Canada in IMS America.
Health Economics in the USA. London, 1996.
Langley PC. The future role of pharmacoeconomics in drug R and D in the United
States. The European Medicines Evaluation Annual Ltd. October 1996.
5
6. Langley PC. Assessing the input costs of disease management programs. Clinical
Therapeutics 1996; 18(6): 1334-1340.
Johnson ES, Sullivan SD, Mozaffari E, Langley PC, Bodsworth NJ. A utility assessment
of oral and intravenous ganciclovir for the maintenance treatment of AIDS-related
cytomegalovirus retinitis. PharmacoEconomics 1996, 10(6): 623-629.
Langley PC, Martin RE. Guidelines for Formulary Submissions. Integrated
Pharmaceutical Services and Foundation Health Corporation, Rancho Cordova, CA.
October 1996.
Langley PC, Martin RE. Analytical and informational requirements in disease
management proposals: A managed care perspective. The Journal of Pharmacy
Technology, 1997; 13(1): 15-20.
Langley PC, Coons SJ. Peripheral Vascular Disorders: A pharmacoeconomic and
quality of life review. PharmacoEconomics 1997; 11(3): 225-236.
Harrison DL, Draugalis JR, Slack MK, Langley PC. Cost-effectiveness of regional
poison control centers. Archives of Internal Medicine 1996; 156: 2601-2608.
Langley PC. The FDA and pharmacoeconomic research. Drug Benefit Trends 1997;
9(1): 17-25.
Hawkins DW, Langley PC, Krueger KP. Pharmacoeconomic model of enoxaparin versus
heparin for prevention of deep vein thrombosis after total hip replacement. American
Journal of Health-System Pharmacy 1997; 54: 1185-1190.
Johnson JA, Coons SJ, Hays RD, Sabers D, Jones P, Langley PC. A comparison of
satisfaction with mail versus traditional pharmacy services. Journal of Managed Care
Pharmacy 1997; 3(3): 327-337.
Langley PC, Bhattacharyyaa SK. Treatment costs, equilibrium and the allocation of the
patients between therapy alternatives. Clinical Therapeutics 1997; 19(1): 830-836.
Langley PC. The Future of Pharmacoeconomics: A Commentary. Clinical Therapeutics,
1997; 19(1): 762-769.
Langley PC, Martin RE. Managed care guidelines for economic evaluation of
pharmaceuticals. American Journal of Managed Care. 1997, 3(7): 1013-1021.
Langley PC. Pharmacoeconomics: Achieving Gold Standards, London: Financial Times
Healthcare, 1997 (145pp.)
Langley PC. Improving health care outcomes through reallocation of health care
expenditures. Clinical Therapeutics, 1997; 19(5): 1092-1100.
6
7. Langley PC and Jacobsen ES, Review and Analysis of Pharmacoeconomic Guidelines,
Spectrum, Decision Resources, Inc., December 1997.
Langley PC. Does pharmacoeconomics have a future? Pharmaceutical News, 1998; 5(1):
7-10.
Langley PC. Pharmacoeconomic evaluations and clinical trials. Applied Clinical Trials,
1998; 7(3): 38-44
Hawkins DW, Langley PC, Krueger KP. A Pharmacoeconomic assessment of
enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing
knee replacement surgery. Clinical Therapeutics, 1998; 20(1): 182-195.
Davies A, Langley PC, Keks NA, Catts SV, Lambert T, Schweitzer I. Risperidone versus
Haloperidol: II. Cost-Effectiveness. Clinical Therapeutics, 1998; 20(1): 196-213.
Kortt MA, Langley PC, Cox ER. A review of cost-of-illness studies on obesity. Clinical
Therapeutics, 1998; 20(4): 772-779.
Langley PC. Disease Management Outcomes, London: Financial Times Healthcare,
1998 (122pp.)
Langley PC. Information requirements of health systems as drug purchasers: does the
FDA have a role in setting evidentiary standards? Journal of Managed Care Pharmacy,
November/December, 1998, 4(6): 593-598.
Langley PC. Criteria for the economic evaluation of lipid studies in health systems.
Value in Health, The Journal of the International Society for Pharmacoeconomics and
Outcomes Research, November/December, 1998, 1(4): 208-211.
Langley PC, Hay JW, Schwartz JS, Smith SC, McKenney J. From research into
practice: how should healthcare organizations/governments decide about lipid
therapy and who will pay? Reactor panel and open forum. Value Health. 1998
Nov;1(4):243-50.
Langley PC, Guidelines for Formulary Submissions for Pharmaceutical Product
Evaluation, Blue Cross and Blue Shield of Colorado and Nevada, Denver, CO.
October 1998.
Langley PC. The technology of metered-dose inhalers and treatment costs in asthma: a
retrospective study of breath actuation versus traditional press-and-breathe inhalers.
Clinical Therapeutics, 1999, 21(1): 236-253.
Langley PC, Tyring SK, Smith MS. The cost effectiveness of patient-applied versus
provider-administered intervention strategies for the treatment of external genital warts.
7
8. American Journal of Managed Care, 1999, 5(1): 69-77.
Langley PC. Meeting the information needs of drug purchasers: The evolution of
formulary submission guidelines, Clinical Therapeutics, 1999; 21(4):768-787.
Richwald GA, Langley PC. Management of external genital warts: Diagnosis and
clinical management, Family Practice Recertification, 1999, 21(9):5-12.
Langley PC, Richwald GA. Management of external genital warts: Pharmacoeconomic
considerations, Family Practice Recertification, 1999, 21(9):13-17.
Armstrong EP and Langley PC. Treatment of Pneumonias in a Managed-Care
Organisation, Disease Management and Health Outcomes, 1999; 6(3): 159-173
Langley PC, Formulary Submission Guidelines for Blue Cross and Blue Shield of
Colorado and Nevada: Structure, Application and Manufacturer Responsibilities,
Pharmacoeconomics, 1999; 16(3): 211-224.
Armstrong EP and Langley PC. The Impact of a Disease Management Intervention on the
Treatment of Infectious Disease in a Managed Care Organization, Disease Management,
1999; 2(3):61-77.
Langley PC, Integrating Pharmacoeconomics into Clinical Trials, Spectrum, Decision
Resources, Inc., June 1999.
Langley PC, Richwald GA and Smith MH. Modeling the impact of treatment options in
genital warts: Patient applied versus physician administered therapies, Clinical
Therapeutics, 1999; 21(12):1-13.
Langley PC, Budget Impacts and Pharmacoeconomic Evaluations, Pharmacoeconomics
and Outcomes News, 19 February 2000, pp. 3-4.
Langley PC, Is Cost-Effectiveness Modeling Useful? (Editorial), American Journal of
Managed Care, 2000; 6(2): 250-251.
W I van der Meijden, A Notowicz, F B Blog and P C Langley, A Retrospective Analysis
of Costs and Patterns of Treatment for External Genital Warts in the Netherlands,
Clinical Therapeutics, January 2002; 24(1):183-196.
P C Langley, Health Economics in the Life cycle of a Drug, Regulatory Affairs Focus,
July 2002.
P C Langley, Health Economics in the Drug Life Cycle, London: Urch Publishing,
November 2002 (135 pp)
P C Langley, The importance of health economics in successfully achieving a sustainable
8
9. price for reimbursement, The Pharmaceutical Pricing Compendium, pp. 49-60 (London:
Urch Publishing, 2003).
P C Langley, Health Economics in Drug Development, Pharmacoeconomics and
Outcomes News Weekly, Adis International, 17 May 2003, pp. 3-5.
P C Langley In all probability …., Scrip Magazine, June 2003.
P C Langley, D White, S Drake, Patterns of Treatment and Resource Utilization in the
Treatment of External Genital Warts in England and Wales: The Results of a Clinical
Audit, International Journal of STD and AIDS, 2004; 15: 473-468.
P C Langley, D White, S Drake, The costs of treating external genital warts in England
and Wales: A treatment pattern analysis, International Journal of STD and AIDS, 2004;
15:501-508.
P C Langley, Focusing Pharmacoeconomic Activities: Reimbursement or the drug life
cycle, Current Medical Research and Opinion, 2004; 20(2): 181-188.
M K Higashi, D L Veenstra, P C Langley, Health Economic Evaluation of Non-
Melanoma Skin Cancer and Actinic Keratosis, Pharmacoeconomics, 2004; 22(2):83-94.
P C Langley, The NICE Reference Case Requirement: Implications for Manufacturers
and Health Systems, Pharmacoeconomics, 2004; 22(4): 267-271.
P C Langley, Recent Developments in the Health Technology Assessment Process in TR
Fulda and A I Wertheimer, Handbook of Pharmaceutical Public Policy, New York,
Haworth Press, 2007, pp. 457-477.
Langley PC. A cost-effectiveness analysis of sinecatechins in the treatment of
external genital warts. J Med Econ. 2010;13(1):1-7
Langley PC, Patkar AD, Boswell KA, Benson CJ, Schein JR. Adverse event profile of
tramadol in recent clinical studies of chronic osteoarthritis pain. Curr Med Res Opin.
2010;26(1):239-51.
Langley PC, Muller-Schwefe G, Nicolaou A et al. The societal impact of pain in the
European Union: health-related quality of life and healthcare resource utilization. J Med
Econ. 2010;13(2):571-81.
Langley PC, Muller-Schwefe G, Nicolaou A et al. The impact of pain on labor force
participation, absenteeism and presenteeism in the European Union. J Med Econ.
2010;13(4):662-72
Langley PC. The prevalence, correlates and treatment of pain in the European
Union. Curr Med Res Opin. 2011 Feb;27(2):463-80.
9
10. Langley P, Ruiz-Iban M, Molina J et al. The prevalence, correlates and treatment of pain
in Spain. J Med Econ. 2011;14(3): 367-80
Langley PC, Mu R, Wu M, Dong P, Tang B The impact of rheumatoid arthritis on the
burden of disease in urban China. J Med Econ. 2011;14(6):709-19
Langley P, Hernandez C, Margarit C, et al. Pain, health related quality of life and
healthcare resource utilization in Spain. J Med Econ. 2011;14(5):628-38
Langley PC, Tornero Molina J, Margarit Ferri C, et al. The association of pain with labor
force participation, absenteeism, and presenteeism in Spain. J Med Econ.
2011;14(6):835-45
Langley PC. The societal burden of pain in Germany: Health related quality of life, health
status and direct medical costs. J Med Econ. 2012 (August epub)
Langley PC, Van Litsenburg C, Cappelleri J et al. The burden associated with
neuropathic pain in Western Europe. J Med Econ. 2013;16(1):85-95
Langley PC, Liedgens H. Time since diagnosis, treatment pathways and current pain
status: a retrospective assessment in a back pain population. J Med Econ.
2013;16(5):701-9
10